Health Glance
The Food and Drug Administration said Friday the highest available dose of Zocor, a component in cholesterol drugs, can cause muscle damage as well as severe and potentially lethal kidney damage.
The agency said statin drugs like Zocor are known to cause muscle damage in some patients, but the risk is more severe when patients are taking 80 milligram doses of Zocor, which is the highest FDA-approved dose.
The side effects include rhabdomyolysis, a form of muscle damage that can lead to kidney damage or failure, and death. Zocor is the brand name for the drug used by Merck & Co. of Whitehouse Station, N.J. Its chemical name is simvastatin.
FDA warns of greater muscle risk from Zocor
Pepsi to pull sugar-sweetened drinks from schools worldwide
Anti-obesity campaigns scored a direct hit today when PepsiCo said it would pull its sugary drinks from schools around the world. PepsiCo, No. 2 worldwide to the Coca-Cola Co., set a 2012 date for removal of all of its full-calorie, sweetened drinks from schools in more than 200 countries by 2012.
PepsiCo, Coca-Cola and others in the industry have already swapped lower-calorie options into schools to replace sugary drinks, under voluntary guidelines adopted in 2006. Sales of full-calorie soft drinks fell 95 percent in U.S. schools between fall 2004 and fall 2009, the American Beverage Association reported last week.
Coke this month said it no longer would sell its other sweetened drinks in grade schools unless parents or school officials asked it to. But Coke didn't extend that change to secondary schools, and today after the Pepsi move Coke said it thought school officials "should have the right to choose what is best for their schools."
Vitamin D better than vaccines at preventing flu, report claims
Vitamin D was found to be even more effective when the comparison left out children who were already given extra vitamin D by their parents, outside the trial. Taking the sunshine vitamin was then shown to reduce the risk of flu to a third of what it would otherwise be.
Embryonic stem cell research stalled despite Obama's try at lifting restrictions
One year after President Obama announced he was lifting his predecessor's controversial restrictions on federal funding for human embryonic stem cell research, some scientists are complaining that so far the new policy is -- ironically -- more of a burden than a boon to their work.
"The situation at the moment is worse than it was under the Bush administration," said Charles Murry, a professor of pathology and bioengineering at the University of Washington in Seattle. "Because of this, we are going to waste a lot of time." At issue is the fate of the 21 "lines of cells" that President George W. Bush said could receive federal funding.
Bush limited federal funding to the lines that were already in existence in 2001. He wanted to prevent taxpayer dollars from encouraging the destruction of more embryos to create more lines. Critics of the research praised Bush's move, arguing that destroying embryos to obtain the cell lines is immoral. But the restrictions were condemned by many scientists, who argued they were hindering research that could lead to cures for Alzheimer's disease, diabetes, paralysis and other ailments.
Story on Mystery Substance Distracts from Fact Fluoride is a Deadly Killer
Exposure to fluoride often results in dental fluorosis. Large numbers of U.S. young people — estimated up to 80 percent in some cities — now have dental fluorosis, the first visible sign of excessive fluoride exposure. Dental fluorosis consists of damage to tooth-forming cells, leading to a defect in tooth enamel. It is also an indicator of fluoride damage to bones.
Novartis drugs fail to help high-risk patients
The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday. The 9,306-patient study tested Starlix, known chemically as nateglinide, and the big-selling Novartis blood pressure medicine Diovan.
Diovan, known chemically as valsartan, reduced progression to diabetes by 14 percent compared to a placebo but failed to reduce the risk of serious heart problems, such as heart attack and stroke, according to researchers who presented the data at the American College of Cardiology scientific meeting in Atlanta.
The failure of Starlix to provide benefit to these patients and lack of heart impact by Diovan came as a surprise to researchers.
Federal Vaccine Court Rules Against Autism Families
Government's Refusal to Fund Sound Science Stacks Deck Against Vaccine-Injured Children and Casts Doubt on the Integrity of the National Immunization Program says SafeMinds.
WASHINGTON, March 12 /PRNewswire-USNewswire/ -- Autism and mercury advocacy organization SafeMinds regrets today's ruling by the U.S. Court of Federal Claims against three families who argued that vaccines which contained the mercury-based preservative thimerosal contributed to their child's autism. The denial of reasonable compensation to families was based on inadequate vaccine safety science and poorly designed and highly controversial epidemiology studies supported by the Centers for Disease Control and Prevention.
More Articles...
Page 161 of 233
